Supportive Intervention for Type 1 Diabetes
(IDEA Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to help older teens and young adults with type 1 diabetes improve blood sugar control using a mix of support tools. Participants will try different combinations of interventions, such as motivational sessions (Motivational Enhancement System), question lists for doctors (Question Prompt List), and text reminders (Text Message Reminders) to better manage diabetes tasks. The trial seeks individuals with type 1 diabetes who have had the condition for at least six months and have struggled with blood sugar control. Those who meet these criteria might find this trial a good opportunity to explore new diabetes management methods. As an unphased trial, this study offers a unique chance to explore innovative diabetes management strategies without the constraints of traditional clinical trial phases.
Do I have to stop taking my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that the treatments tested in this project are generally safe and well-tolerated.
For the Motivational Enhancement System (MES), studies indicate that motivational interviewing, a component of this system, helps individuals with Type 1 Diabetes (T1D) improve self-care. Previous participants reported no major safety issues, and this approach is considered safe as it focuses on enhancing communication and motivation.
The Question Prompt List (QPL) is also safe. It consists of questions that help patients communicate more effectively with their healthcare team. Research shows it can boost confidence and involvement in healthcare discussions, with no known risks.
Text Message Reminders (TXT) have been widely studied. Research indicates they are safe and assist individuals in better managing their diabetes. In studies, teens who received text reminders demonstrated improved blood sugar control without any safety concerns.
Overall, these behavioral and motivational tools aim to support diabetes management without posing risks to participants.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores innovative, supportive interventions for managing Type 1 Diabetes (T1D) beyond traditional medical care, which typically involves regular monitoring and insulin therapy. The Motivational Enhancement System (MES) stands out by using a computer-delivered approach to boost intrinsic motivation for self-management, leveraging techniques from motivational interviewing. The Question Prompt List (QPL) empowers patients by providing them with a structured list of questions to engage more effectively with their healthcare providers during clinic visits. Text Message Reminders (TXT) offer a tech-savvy way to keep patients on track with daily diabetes care tasks like blood glucose monitoring and insulin administration. By integrating these methods, researchers hope to enhance patient engagement and self-efficacy, potentially leading to better health outcomes for those living with T1D.
What evidence suggests that this trial's treatments could be effective for improving metabolic control in older adolescents and emerging adults with Type 1 Diabetes?
Studies have shown that the Motivational Enhancement System (MES), one of the interventions in this trial, can help lower HbA1c levels, a measure of blood sugar control, in people with type 1 diabetes. It employs techniques like motivational interviewing to encourage better self-care habits. Another intervention, the Question Prompt List (QPL), can enhance patient communication with their healthcare team, although results vary. Some studies suggest these tools can improve diabetes management. Text Message Reminders (TXT), also tested in this trial, have improved blood sugar control when participants use them regularly. These reminders assist patients in remembering important daily diabetes tasks like checking blood sugar and taking insulin.678910
Who Is on the Research Team?
April Carcone, PhD
Principal Investigator
Wayne State University
Are You a Good Fit for This Trial?
This trial is for young people aged 16-25 with Type 1 Diabetes who have had high blood sugar levels over the past six months. Participants must speak and write English, be able to text, and have been diagnosed with diabetes for at least half a year. It's not open to those with severe mental health issues, developmental delays, or other conditions affecting diabetes management.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a multi-component behavioral intervention including MES, QPL, and TXT to improve metabolic control
Follow-up
Participants are monitored for changes in HbA1c and diabetes management behaviors post-treatment
What Are the Treatments Tested in This Trial?
Interventions
- Motivational Enhancement System (MES)
- Question Prompt List (QPL)
- Text Message Reminders (TXT)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Wayne State University
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator